FOLDERS
You are here: For the applicantsNews and eventsEventsHungarian and international events
Topics under consideration for inclusion in future Calls for proposals under Innovative Medicines Initiative 2 (IMI2)
Topics under consideration for inclusion in future Calls for proposals under Innovative Medicines Initiative 2 (IMI2)
02 June 2014
Modified: 14 December 2017
Reading time: 2 minute(s)
Share
ShareShare
Print
PrintPrint
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.

The total budget proposed for IMI 2 is €3.3 billion. The EU will contribute up to €1.6 billion of this from Horizon 2020, the EU research and innovation framework programme. EFPIA, the European Federation of Pharmaceutical Industries and Associations, will commit €1.6 billion in in kind contributions. In addition, other life science industries may contribute a further €225 million if they decide to join IMI 2 as members or as partners in individual projects.

IMI 2 will start in 2014 and will run for 10 years.

The following topics are under consideration for inclusion in the Calls for proposals that will be launched in 2014 under IMI 2:

IMI 2 - Call 1

  • Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
    Read the indicative topic text
  • Discovery and validation of novel endpoints in retinal diseases
    Read the indicative topic text

Future topics - IMI 2 2014

All information regarding IMI 2 and future Calls for proposals is indicative and subject to the approval of the IMI 2 legislative package and the agreement of the IMI Governing Board on the Call topics

Updated: 14 December 2017
Feedback
Was this page helpful?
Yes
No
None of relevance
On this webpage we use http cookies for providing safe browsing and the best user experience. In our Data Protection Information you can find further information about how we care about the protection of your data.
OK